Loss of the Endothelial Glycocalyx Component EMCN Leads to Glomerular Impairment
Circulation Research · 2025
DOI: 10.1161/circresaha.124.325218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, 2025. Verfasst von Zhengping Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA (Z.H., I.C., F.L., J.L., H.G., E.I.P., M.S.-G., Y.S.E.N., P.A.D.). Hauptthemen laut MEDLINE: Glycocalyx, Mice, Knockout, Kidney Glomerulus, Podocytes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: EMCN (endomucin), an endothelial-specific glycocalyx component, was found to be highly expressed by the endothelium of the renal glomerulus. We reported an anti-inflammatory role of EMCN and its involvement in the regulation of VEGF (vascular endothelial growth factor) activity through modulating VEGFR2 (VEGF receptor 2) endocytosis. The goal of this study is to investigate the phenotypic and functional effects of EMCN deficiency using the first global EMCN knockout mouse model. METHODS: Global EMCN knockout mice were generated by crossing EMCN-floxed mice with ROSA26-Cre mice. Flow cytometry was used to analyze infiltrating myeloid cells in the kidneys. The ultrastructure of the glomerular filtration barrier was examined by transmission electron microscopy, whereas urinary albumin, creatinine, and total protein levels were analyzed from freshly collected urine samples. Expression and localization of EMCN, EGFP (enhanced green fluorescent protein), CD45 (cluster of differentiation 45), CD31, CD34, podocin, and albumin were examined by immunohistochemistry. Mice were weighed regularly, and their systemic blood pressure was measured using a noninvasive tail-cuff system. Glomerular endothelial cells and podocytes were isolated by fluorescence-activated cell sorting for RNA sequencing. Transcriptional profiles were analyzed to identify differentially expressed genes in both endothelium and podocytes, followed by gene ontology analysis. Protein levels of EMCN, albumin, and podocin were quantified by Western blot. RESULTS: The EMCN −/− mice exhibited increased infiltration of CD45 + cells, with an increased proportion of Ly6G high Ly6C high myeloid cells and higher VCAM-1 (vascular cell adhesion molecule 1) expression. EMCN −/− mice displayed albuminuria with increased albumin in the Bowman’s space compared with the EMCN +/+ littermates. Glomeruli in EMCN −/− mice revealed fused and effaced podocyte foot processes and disorganized endothelial fenestrations. We found no significant difference in blood pressure between EMCN knockout mice and their wild-type littermates. RNA sequencing of glomerular endothelial cells revealed downregulation of cell-cell adhesion and MAPK (mitogen-activated protein kinase)/ERK (extracellular signal–regulated kinase) pathways, along with glycocalyx and extracellular matrix remodeling. In podocytes, we observed reduced VEGF signaling and alterations in cytoskeletal organization. Notably, there was a significant decrease in both mRNA and protein levels of podocin, a key component of the slit diaphragm. CONCLUSION: Our study demonstrates a critical role of the endothelial marker EMCN in supporting normal glomerular filtration barrier structure and function by maintaining glomerular endothelial tight junction and homeostasis and podocyte function through endothelial-podocyte crosstalk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA (Z.H., I.C., F.L., J.L., H.G., E.I.P., M.S.-G., Y.S.E.N., P.A.D.).
- Department of Ophthalmology (Z.H., I.C., F.L., J.L., H.G., E.I.P., M.S.-G., Y.S.E.N., P.A.D.), Harvard Medical School, Boston, MA.
- Department of Molecular and Cellular Physiology, Albany Medical Center, NY (R.B.R.).
- Now with Biomedical Research, Novartis, Cambridge, MA (M.S.-G.).
- Now with EyeBiotech Limited, a subsidiary of Merck & Co, Inc, Rahway, NJ (Y.S.E.N.).
- Department of Pathology (P.A.D.), Harvard Medical School, Boston, MA.
ORCID-Profile: Zhengping Hu, Issahy Cano, Fengyang Lei, Jie Liu, Ramon Bossardi Ramos, Harper Gordon, Eleftherios I Paschalis, Magali Saint-Geniez, Yin Shan Eric Ng, Patricia A D'Amore
Förderung
- NEI NIH HHS
Zitieren
APA
Hu, Z., Cano, I., Lei, F., Liu, J., Bossardi Ramos, R., Gordon, H., Paschalis, E. I., Saint-Geniez, M., Ng, Y. S. E., & D'Amore, P. A. (2025). Loss of the Endothelial Glycocalyx Component EMCN Leads to Glomerular Impairment. Circulation Research. https://doi.org/10.1161/circresaha.124.325218
Vancouver
Hu Z, Cano I, Lei F, Liu J, Bossardi Ramos R, Gordon H, et al. Loss of the Endothelial Glycocalyx Component EMCN Leads to Glomerular Impairment. Circulation Research. 2025. doi:10.1161/circresaha.124.325218
BibTeX
@article{Hu2025,
author = {Hu, Zhengping and Cano, Issahy and Lei, Fengyang and Liu, Jie and Bossardi Ramos, Ramon and Gordon, Harper and Paschalis, Eleftherios I and Saint-Geniez, Magali and Ng, Yin Shan Eric and D'Amore, Patricia A},
title = {Loss of the Endothelial Glycocalyx Component EMCN Leads to Glomerular Impairment},
journal = {Circulation Research},
year = {2025},
doi = {10.1161/circresaha.124.325218}
}
EUVIMED